Filing Details

Accession Number:
0000899243-21-004962
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-04 17:56:12
Reporting Period:
2021-02-02
Accepted Time:
2021-02-04 17:56:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1694665 Evelo Biosciences Inc. EVLO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222012 Noubar Afeyan 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1503559 Flagship Ventures Fund Iv, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1508051 Flagship Ventures Fund Iv General Partner Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1590973 Flagship Ventures Fund Iv-Rx, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1677345 Flagship Ventures Opportunities Fund I, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1725004 Flagship Ventures Opportunities Fund I General Partner Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1780951 Nutritional Health Ltp Fund General Partner Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1780956 Nutritional Health Ltp Fund, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-02 37,143 $15.00 3,207,312 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-02-02 9,285 $15.00 791,529 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-02-02 37,143 $15.00 1,370,476 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-02-02 46,429 $15.00 4,125,461 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 684,372 Indirect See Footnote
Common Stock 2,645,637 Indirect See Footnote
Common Stock 4,201,284 Indirect See Footnote
Common Stock 1,609,871 Indirect See Footnote
Common Stock 795,950 Indirect See Footnote
Common Stock 3,598,177 Indirect See Footnote
Footnotes
  1. On February 2, 2021, Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") acquired 37,143 shares pursuant to an underwritten public offering of common stock by the Issuer (the "Offering").
  2. Shares held by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  3. On February 2, 2021, Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx") acquired 9,285 shares pursuant to the offering.
  4. Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Dr. Afeyan is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  5. On February 2, 2021, Nutritional Health LTP Fund, L.P. ("Nutritional LTP") acquired 37,143 shares pursuant to the Offering.
  6. Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Dr. Afeyan is the sole member and manager of Nutritional LTP GP. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  7. On February 2, 2021, Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities I") acquired 46,429 shares pursuant to the Offering.
  8. Shares held by Flagship Opportunities I. Flagship Ventures Opportunities Fund I General Partner LLC ("Flagship Opportunities GP") is the general partner of Flagship Opportunities I. Dr. Afeyan is the sole manager of Flagship Opportunities GP. Each of the reporting persons except for Flagship Opportunities I disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  9. Shares held by Flagship VentureLabs IV, LLC ("VentureLabs IV"). Flagship Fund IV is a member of VentureLabs IV and also serves as its manager. Flagship Fund IV GP is the general partner of Flagship Fund IV. Dr. Afeyan is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  10. Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") serves as manager of VentureLabs V. Flagship Pioneering is the manager of VentureLabs V Manager. Dr. Afeyan serves as sole director of Flagship Pioneering. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  11. Shares held by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship Ventures Fund V General Partner LLC ("Flagship Fund V GP") is the general partner of Flagship Fund V. Dr. Afeyan serves as sole manager of Flagship Fund V. Each of the reporting persons except for Flagship Fund V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  12. Shares held by Flagship V VentureLabs Rx Fund, L.P. ("VentureLabs Rx V"). Flagship Fund V GP is the general partner of VentureLabs Rx V. Dr. Afeyan serves as sole manager of Flagship Fund V GP. Each of the reporting persons except for VentureLabs Rx V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  13. Shares held by Nutritional Health Side Fund, L.P. ("Nutritional Health Side Fund"). Flagship Fund V GP is the general partner of Nutritional Health Side Fund. Dr. Afeyan serves as sole manager of Flagship Fund V GP. Each of the reporting persons except for Nutritional Health Side Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  14. Shares held by Nutritional Health Disruptive Innovation Fund, L.P. ("Nutritional Innovation Fund"). Flagship Fund V GP is the general partner of Nutritional Innovation Fund. Dr. Afeyan serves as sole manager of Flagship Fund V GP. Each of the reporting persons except for Nutritional Innovation Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.